Alzheimer'S Disease Clinical Trials in Miami, FL

Alzheimer'S Disease Clinical Trials in Miami, FL

View the best 10 alzheimer's disease medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Alzheimer'S Disease clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for alzheimer's disease in Miami, Florida

Image of Ah0003 50423 in East Providence, United States.

Bepranemab

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing bepranemab, a new medication, to see if it can help people with early-stage Alzheimer's disease. The study focuses on individuals who are just starting to show symptoms or have mild symptoms. Bepranemab works by removing harmful proteins from the brain that are linked to Alzheimer's.
Image of Optimus U Corporation in Miami, United States.

Placebo +1 More

Recruiting0 awardsPhase 2
This trial will test if a drug can safely and effectively treat Alzheimer's disease.
Image of NYU Langone Health in New York, United States.

Exercise Routine

Behavioural Intervention

Recruiting1 award4 criteria
This trial is studying whether better sleep and more exercise can reduce the risk of dementia in people who are at risk. The idea is that these lifestyle changes might help keep the brain healthy.
Image of Valley Clinical Trials, Inc. in Covina, United States.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Image of Banner Sun Health Research Institute in Sun City, United States.

Escitalopram

Selective Serotonin Reuptake Inhibitor

Recruiting2 awardsPhase 3
This trial will test whether the antidepressant escitalopram is effective and safe for treating agitation in Alzheimer's dementia.
Image of Novo Nordisk Investigational Site in Lomita, United States.

Semaglutide

Glucagon-like peptide-1 (GLP-1) receptor agonist

Recruiting1 awardPhase 3
This trial is to test whether the medication semaglutide has a positive effect on early Alzheimer's disease. The study will last for up to 173 weeks, and participants will have 17 clinic visits and 1 phone call with the study doctor. The study includes various tests and scans, and at 10 of the clinic visits participants will have blood samples taken. The trial is only for women.
Image of Mount Sinai Medical Center in Miami Beach, United States.

Brain CareNotes

Behavioural Intervention

Recruiting1 award3 criteria
This trial will test if a mobile health app can reduce the burden of unpaid Hispanic caregivers of dementia patients and improve BPSD symptoms in the care recipients.
Image of GSK Investigational Site in DeLand, United States.

GSK4527226

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial will study if a new drug is safe and effective in people with early Alzheimer's, including mild cognitive impairment and mild dementia.
Image of PROSOMNIA Sleep Health and Wellness in Aventura, United States.

PROSOMNIA Sleep Therapy™ (PSTx)

Behavioural Intervention

Recruiting1 awardPhase 1
This trial aims to test a new therapy called PROSOMNIA Sleep Therapy (PSTx) for people with chronic insomnia and REM sleep disorders. The therapy uses anesthesia to improve the quality and
Image of Aventura Neurologic Associates in Miami, United States.

GV1001

Cancer Vaccine

Recruiting0 awardsPhase 2
This trialis testing a drug (GV1001) to treat mild to moderate Alzheimer's disease by reducing the amount of proteins that damage the brain. In a completed study, the drug showed promising results and was safe.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.